NANOCOMBO project: exploring opportunities in drug repurposing associated with multi-drug combination

Drug combination is a very powerful approach to design and tailor efficient treatment . Our nanodrop technology have the same size than a coronavirus and can be loaded with targeting synthons (RGD peptide, for example).

We are looking for academics/SMEs interested in exploring with us our NANOCOMBO approach. Our technology is suitable for any administration route in any therapeutic field.

We currently develop a drug repurposing approach applied to cancer solid tumor treatment (Glioblastoma) in murine preclinical models.

We seek for experts in organoids, PDX models, PK/PD, imaging, digital twins , to extend the strategy to other types of cancer.